CN1048162C - Regeneration pill for curing spinal nerve injury - Google Patents
Regeneration pill for curing spinal nerve injury Download PDFInfo
- Publication number
- CN1048162C CN1048162C CN93107525A CN93107525A CN1048162C CN 1048162 C CN1048162 C CN 1048162C CN 93107525 A CN93107525 A CN 93107525A CN 93107525 A CN93107525 A CN 93107525A CN 1048162 C CN1048162 C CN 1048162C
- Authority
- CN
- China
- Prior art keywords
- processed
- semen strychni
- moschus
- myrrha
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Abstract
The present invention relates to a regeneration pill for curing spinal nerve injuries, which selects medicines according to a principle of promoting blood circulation for removing blood stasis, and is prepared from saffron, notoginseng, fried pangolin, raw ephedra, raw curare, etc. The regeneration pill used for treating a patient of traumatic paraplegia can predominantly promote the restoration and the regeneration of the function of the spinal nerves, the regeneration pill has a total effective rate of 89.9%., an effective rate of 75%, and a rate of basic life self-care of the patient is 57%.
Description
The present invention relates to a kind of medicine, particularly is the pharmaceuticals of raw material with the Chinese herbal medicine.
Vertebra exogenous injury dislocation merges spinal cord injury and causes paraplegia, is one of difficult and complicated illness in the world now.So-called traumatic paralysis is meant because of extraneous violence effect causes cervical vertebra, thoracic vertebra, lumbar vertebra fracture, dislocation, intervertebral disk hernia, and dura mater is dampened, hematoma, thereby makes spinal nerves fracture or pressurized, afunction.After the function of spinal nerves forfeiture, cause patient to produce following clinical symptoms: the following dyskinesia in paraplegia plane, anesthesia, gatism, amyotrophy then takes place in that continues, and pipe is foster bad, decubital ulcer, complication such as urinary system infection.
Treatment to this paraplegia, the doctor trained in Western medicine scholar of China and foreign countries is more with the treatment of operation laminectomy for decompression, main purpose is to make pathological changes subduction such as spinal cord due to the vertebral body displacement or cauda equina nerve contusion, laceration or concussion injury or alleviate, and its clinical cure rate (reaching life is basic takes care of oneself) is between 15-20%; Traditional Chinese medical science scholar then with acupuncture, method treatment such as massage, take medicine.Wherein, be the representative prescription with great achievement soup and Fuyuan Huoxue Tang in the Chinese medicine, its cure rate is between 5-10%.Make a general survey of the treatment of Chinese and western medicine scholar to this disease, its curative effect is unsatisfactory, thereby makes this disease become one of thorny in the world difficult disease.
The objective of the invention is to develop a kind of spinal nerves medicament, it can remove traumatic paralysis patient's slight illness, makes function major part such as the following nerve in paraplegia plane, muscle or full recovery normal, and life can take care of oneself basically.
The object of the present invention is achieved like this: with the theory of the traditional Chinese medical science " the blood stasis of blood of not living can not be dispelled, and the stasis of blood bone of can not dispelling can not connect " for instructing determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, with " blood circulation promoting and blood stasis dispelling " as the selection principle of being used as medicine, be made into prescription, reach the purpose of treatment, its basic prescription is:
A kind of Chinese medicine preparation for the treatment of traumatic paralysis, its basic comprising is: it is made up of Stigma Croci, Radix Notoginseng, Squama Manis (processed), Sanguis Draxonis, Olibanum (processed), Myrrha (processed), Semen Strychni, Herba Ephedrae, Moschus, and each component content unit is by weight counted:
Stigma Croci: 2-4;
Radix Notoginseng: 1-2;
Squama Manis (processed): 1-2;
Sanguis Draxonis: 2-4;
Olibanum (processed): 2-4;
Myrrha (processed): 2-4;
Semen Strychni: 2-3.5;
Herba Ephedrae: 0.2-0.35;
Moschus: 0.1-0.15.
The invention will be further described below with reference to embodiment.
Acting as of each component medicine: Stigma Croci, Radix Notoginseng, Sanguis Draxonis, Olibanum (processed), Myrrha (processed), energy anti-inflammatory analgetic, blood circulation promoting and blood stasis dispelling, promoting tissue regeneration by removing blood stasis, reunion of bone, clinical application effect is very good; Semen Strychni, it has closed alkaloid and brucine, has stimulating central nervous system, promotes microcirculation, vasospasmolytic effect.It is acted on spinal cord, can make impulsion between neuron, be easy to conduction, and can guide all medicines through sick institute; Herba Ephedrae energy expelling wind and removing dampness; Moschus energy promoting blood circulation and detumescence, suffering are loose and are walked to scurry, and control sore swollen toxin, traumatic injury etc.; Squama Manis (processed) energy dredging the meridian makes nerve recovery and regeneration.More than these several herbal medicines make prescription, can the principal and subordinate make a concerted effort, complement each other, altogether the effect of tool blood circulation promoting and blood stasis dispelling, reunion of bone, excited spinal cord, regenerating nerve, expelling wind and removing dampness, dredging the meridian.
When said medicine was made prescription, operation as follows: with Semen Strychni with Cortex Cinnamomi, Radix Glycyrrhizae together, in 1: 0.1-0.23: the ratio of 0.2-0.3 was weighed water logging 7-10 days, the malicious sustainability of dispelling, peeling, cut into slices dry be crushed into powder standby.Also be ground into powder (about about 100 orders) after other medicines are weighed by prescription, then with the Semen Strychni mixing the powder finished product.Take for ease of the patient, preferably make capsule again, every can be by 0.3 gram counterweight.
Three embodiment of the present invention are:
Medicine name prescription 1 dosage prescription 2 dosage prescriptions 3 dosage
Stigma Croci 2.3 4 2.7
Radix Notoginseng 1.7 1.2 2
Squama Manis (processed) 1.0 1.6 1.3
Sanguis Draxonis 2.9 4 2.7
Semen Strychni 2.8 3 3.3
Olibanum (processed) 3.1 2.8 3.6
Myrrha (processed) 4 2.5 2.7
Herba Ephedrae 0.27 0.24 0.29
Moschus 0.14 0.11 0.13
Chinese medicine preparation capsule by the present invention makes is used for orally taken for curing wound paralyses patient, and total effective rate reaches 89.9%.Obvious effective rate reaches 75%, and the basic self-care rate of living reaches 57%, some patient even recovered certain work capacity.One group of patient according to nearest clinic observation, totally 68 examples, wherein, complete paraplegia 31 examples, incomplete paraplegia 37 examples are after treatment, the recovery from illness or 23 examples that are almost recovered, more good 27 examples that account in back still can account for 12 examples after healing, more relatively poor 6 examples that account in back, these case proofs capsule of the present invention is to the limbs of paralyses patient, the recovery of muscle and fecal and urinary functions has important role really, all after wound or continuous medication treatment 4-6 month the patient of postoperative, its curative effect is very good, otherwise, recover drug withdrawal because of function is temporary transient, fail to consolidate curative effect, the function of nervous system of having recovered also may tend to disappear.The case of this pros and cons has proved that fully medicament of the present invention is to influence that spinal nerves produced.
Claims (3)
1. a Chinese medicine preparation for the treatment of traumatic paralysis is characterized in that, it is made by Stigma Croci, Radix Notoginseng, Squama Manis (processed), Sanguis Draxonis, Olibanum (processed), Myrrha (processed), Semen Strychni, Herba Ephedrae, Moschus, and each component content unit is by weight counted:
Stigma Croci: 2-4;
Radix Notoginseng: 1-2;
Squama Manis (processed): 1-2;
Sanguis Draxonis: 2-4;
Olibanum (processed): 2-4;
Myrrha (processed): 2-4;
Semen Strychni: 2-3.5;
Herba Ephedrae: 0.2-0.35;
Moschus: 0.1-0.15.
2. a manufacture method for the treatment of the Chinese medicine preparation of traumatic paralysis is characterized in that, said preparation is made by Stigma Croci, Radix Notoginseng, Squama Manis (processed), Sanguis Draxonis, Olibanum (processed), Myrrha (processed), Semen Strychni, Herba Ephedrae, Moschus, and each component content unit is by weight counted:
Stigma Croci: 2-4;
Radix Notoginseng: 1-2;
Squama Manis (processed): 1-2;
Sanguis Draxonis: 2-4;
Olibanum (processed): 2-4;
Myrrha (processed): 2-4;
Semen Strychni: 2-3.5;
Herba Ephedrae: 0.2-0.35;
Moschus: 0.1-0.15;
Above-mentioned each component medicine is weighed by ratio requirement, and with Semen Strychni with Cortex Cinnamomi, Radix Glycyrrhizae together, in 1: 0.1-0.23: the water logging of weighing of the ratio of 0.2-0.3 was steeped 7-10 days, peeling, cut into slices, dry, pulverize, other medicines also are ground into powder, mixing gets product then.
3. according to the manufacture method of the described Chinese medicine preparation of claim 2, it is characterized in that, described powder is made capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93107525A CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93107525A CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1102099A CN1102099A (en) | 1995-05-03 |
CN1048162C true CN1048162C (en) | 2000-01-12 |
Family
ID=4986740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93107525A Expired - Lifetime CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1048162C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1630528A (en) * | 1999-08-30 | 2005-06-22 | 独立行政法人科学技术振兴机构 | Brain cell or nerve cell protecting agents comprising ginseng |
CN107281353A (en) * | 2017-08-18 | 2017-10-24 | 赵彩红 | A kind of Chinese medicine of promotion nerve regneration |
-
1993
- 1993-06-30 CN CN93107525A patent/CN1048162C/en not_active Expired - Lifetime
Non-Patent Citations (5)
Title |
---|
《中医药信息》1986年4月1日 1986.4.30 余锡明,马钱子在脊柱损伤疾患中的应用 * |
《中西医结合杂志》1991-11-1 1991.1.30 黄中湖/中西医结合治疗外伤性不全截瘫5例 * |
《江西中医药》1990,21(6) 1990.6.30 熊这 熊赛君/膈下通瘰痃汤治疗外伤性截瘫尿潴留15例 * |
《河南中医》1986,(2) 1986.2.28 吴一渊/毒药猛剂善起治疗 * |
《河南中医》1986,(2) 1986.2.28 吴一渊/毒药猛剂善起治疗;《江西中医药》1990,21(6) 1990.6.30 熊这 熊赛君/膈下通瘰痃汤治疗外伤性截瘫尿潴留15例;《中西医结合杂志》1991-11-1 1991.1.30 黄中湖/中西医结合治疗外伤性不全截瘫5例;《中医药信息》1986年4月1日 1986.4.30 余锡明,马钱子在脊柱损伤疾患中的应用 * |
Also Published As
Publication number | Publication date |
---|---|
CN1102099A (en) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1899403A (en) | Chinese medicine preparation for treating pains and its preparing method and use | |
CN1092981C (en) | Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method | |
CN1977933A (en) | Bone-setting medicine and its use method | |
CN1048162C (en) | Regeneration pill for curing spinal nerve injury | |
CN1235630C (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
CN1242774C (en) | Medicine for curing proliferation arthritis of spine and its preparation method | |
CN1181878C (en) | Detumescence plaster | |
CN1054071C (en) | Universal injury liquid and its prepn. method | |
CN1903354A (en) | Traditional Chinese medicine for treating lumbago and skelalgia | |
CN1380071A (en) | Chinese medicine for curing psychosis and epilepsy | |
CN1723933A (en) | Traditional Chinese medicine capsule for treating application, and its prodn. method | |
CN1239174C (en) | Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method | |
CN1411861A (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
CN1100556C (en) | Liquid Chinese medicine for treating rheumatism | |
CN1058409C (en) | Medicine for quickly curing osteoproliferation | |
CN1066626C (en) | Traumatic paraplegia pills or capsules | |
CN1262110A (en) | Medicine for treating pain of lumbus, leg, neck and shoulder | |
CN1539448A (en) | Drug for curing reheumatoid arthritis and atrophic artjritis | |
CN112089786A (en) | Multifunctional traditional Chinese medicine compound composition and application thereof in pharmaceutical preparation | |
CN1839974A (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
CN104623050B (en) | A kind of medicament for the treatment of corticosteroid femur head necrosis | |
CN105287747A (en) | Traditional Chinese medicine composition for treating spinal cord injury as well as preparation method and application thereof | |
CN1166975A (en) | High-efficiency liniment for bone injury and chilblain | |
CN1230192C (en) | Medicine for treating protrasion of the lumbar intervertebral and preparation method | |
CN1175852C (en) | Medicine for treating hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20130630 Granted publication date: 20000112 |